315
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Obstacles to Early Diagnosis and Treatment of Pruritus in Patients with Chronic Kidney Disease: Current Perspectives

ORCID Icon, , &
Pages 335-352 | Received 02 Jul 2022, Accepted 15 Nov 2022, Published online: 06 Dec 2022

References

  • Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7):535–547. doi:10.1038/nrn1950
  • Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the international forum for the study of Itch. Acta Derm Venereol. 2007;87(4):291–294. doi:10.2340/00015555-0305
  • Ross SE. Pain and itch: insights into the neural circuits of aversive somatosensation in health and disease. Curr Opin Neurobiol. 2011;21(6):880–887. doi:10.1016/j.conb.2011.10.012
  • Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444(7121):894–898. doi:10.1038/nature05413
  • Sandroni P, Martin DP, Bruce BK, Rome JD. Congenital idiopathic inability to perceive pain: a new syndrome of insensitivity to pain and itch with preserved small fibers. Pain. 2006;122(1–2):210–215. doi:10.1016/j.pain.2006.01.033
  • Saxena AK. ”Uremic pruritus”: a misnomer. Hemodial Int. 2005;9(4):416–417. doi:10.1111/j.1542-4758.2005.01161.x
  • Page MJ et al . (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, n71. doi: 10.1136/bmj.n71
  • Young AW, Sweeney EW, David DS, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med. 1973;73(22):2670–2674.
  • Wulczyn KE, Zhao SH, Rhee EP, Kalim S, Shafi T. Trajectories of uremic symptom severity and kidney function in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2022;17:496–506. doi:10.2215/CJN.13010921
  • Sukul N, Speyer E, Tu C, et al. Pruritus and patient reported outcomes in non-dialysis CKD. Clin J Am Soc Nephrol. 2019;14(5):673–681. doi:10.2215/CJN.09600818
  • van der Willik EM, Lengton R, Hemmelder MH, et al. Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms - results from the RENINE/PROMs registry. Nephrol Dial Transplant. 2022;37:1731–1741. doi:10.1093/ndt/gfac022
  • Pisoni RL, Wikström B, Elder SJ, et al. Pruritus in hemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–3505. doi:10.1093/ndt/gfl461
  • Sukul N, Karaboyas A, Csomor PA, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Medicine. 2021;3(1):42–53.e1. doi:10.1016/j.xkme.2020.08.011
  • Kimata NFD, Saito A, Akizawa T, et al. Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Hemodial Int. 2014;18(3):657–667. doi:10.1111/hdi.12158
  • Ramakrishnan K, Bond TC, Claxton A, et al. Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis. 2013;7:1–12. doi:10.2147/IJNRD.S52985
  • Mathur VS, Lindberg J, Germain M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410–1419. doi:10.2215/cjn.00100110
  • Hu X, Sang Y, Yang M, Chen X, Tang W. Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients. Medicine. 2018;97(21):e10633. doi:10.1097/md.0000000000010633
  • Weiss M, Mettang T, Tschulena U, et al. Health-related quality of life in haemodialysis patients suffering from chronic itch: results from GEHIS (German Epidemiology Haemodialysis Itch Study). Qual Life Res. 2016;25(12):3097–3106. doi:10.1007/s11136-016-1340-4
  • Gatmiri SM, Mahdavi-Mazdeh M, Lessan-Pezeshki M, Abbasi M. Uremic pruritus and serum phosphorus level. Acta Med Iran. 2013;51:477–481.
  • Tessari G, Dalle Vedove C, Loschiavo C, et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol. 2009;22(2):241–248.
  • Mettang T, Fritz P, Weber J, Machleidt C, Hübel E, Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990;34(3):136–141.
  • Rayner HC, Larkina M, Wang M, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000–2007. doi:10.2215/CJN.03280317
  • Weiss M, Mettang T, Tschulena U, Passlick-Deetjen J, Weisshaar E. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol. 2015;95(7):816–821. doi:10.2340/00015555-2087
  • Hayani K, Weiss M, Weisshaar E. Clinical findings and provision of care in haemodialysis patients with chronic itch: new results from the German epidemiological haemodialysis itch study. Acta Derm Venereol. 2016;96(3):361–366. doi:10.2340/00015555-2280
  • Ibrahim MK, Elshahid AR, El Baz TZ, Elazab RM, Elhoseiny SA, Elsaie ML. Impact of uraemic pruritus on quality of life among end stage renal disease patients on dialysis. J Clin Diagn Res. 2016;10(3):WC01–WC5. doi:10.7860/JCDR/2016/16273.7488
  • Lopes GB, Nogueira FC, de Souza MR, et al. Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form. Qual Life Res. 2012;21(4):603–612. doi:10.1007/s11136-011-9964-x
  • Plewig N, Ofenloch R, Mettang T, Weisshaar E. The course of chronic itch in hemodialysis patients: results of a 4-year follow-up study of GEHIS (German Epidemiological Hemodialysis Itch Study). J Eur Acad Dermatol Venereol. 2019;33(7):1429–1435. doi:10.1111/jdv.15483
  • Satti MZ, Arshad D, Javed H, et al. Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients. Cureus. 2019;11(7):e5178. doi:10.7759/cureus.5178
  • Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69(9):1626–1632. doi:10.1038/sj.ki.5000251
  • Arzhan S, Roumelioti ME, Unruh ML. Itch and ache on dialysis: new approaches to manage uremic pruritus and restless legs. Blood Purif. 2020;49(1–2):222–227. doi:10.1159/000504081
  • Scherer JS, Combs SA, Brennan F. Sleep disorders, restless legs syndrome, and uremic pruritus: diagnosis and treatment of common symptoms in dialysis patients. Am J Kidney Dis. 2017;69(1):117–128. doi:10.1053/j.ajkd.2016.07.031
  • Mettang T, Kremer AE. Uremic pruritus. Kidney Int. 2015;87(4):685–691. doi:10.1038/ki.2013.454
  • Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management. Kidney Int Rep. 2020;5(9):1387–1402. doi:10.1016/j.ekir.2020.04.027
  • Gilchrest BA, Stern RS, Steinman TI, Brown RS, Arndt KA, Anderson WW. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol. 1982;118(3):154–156. doi:10.1001/archderm.1982.01650150016012
  • Aresi G, Rayner HC, Hassan L, et al. Reasons for underreporting of uremic pruritus in people with chronic kidney disease: a qualitative study. J Pain Symptom Manage. 2019;58(4):578–586.e2. doi:10.1016/j.jpainsymman.2019.06.010
  • Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49(5):842–846. doi:10.1016/s0190-9622(03)02478-2
  • Raj R, Ahuja K, Frandsen M, Murtagh FEM, Jose M. Validation of the IPOS-renal symptom survey in advanced kidney disease: a cross-sectional study. J Pain Symptom Manage. 2018;56(2):281–287. doi:10.1016/j.jpainsymman.2018.04.006
  • Palliative Care Outcome Scale. IPOS-Renal for kidney disease patients. Available from: https://pos-pal.org/maix/ipos-renal.php. Accessed November 15, 2022.
  • Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28(4):270–284. doi:10.1097/00002820-200507000-00005
  • Miaskowski C, Barsevick A, Berger A, et al. Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst. 2017;109(4):djw253. doi:10.1093/jnci/djw253
  • Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs. 2012;35(6):E1–E20. doi:10.1097/NCC.0b013e318233a81
  • Lockwood MB, Lash JP, Pauls H, et al. Physical symptom cluster subgroups in chronic kidney disease. Nurs Res. 2020;69(2):100–108. doi:10.1097/NNR.0000000000000408
  • Wu HY, Huang JW, Tsai WC, et al. Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: a prospective cohort study. PLoS One. 2018;13(9):e0203474. doi:10.1371/journal.pone.0203474
  • Krajewski PK, Krajewska M, Szepietowski JC. Pruritus in renal transplant recipients: current state of knowledge. Adv Clin Exp Med. 2020;29(6):769–772. doi:10.17219/acem/122174
  • Schricker S, Weisshaar E, Kupfer J, Mettang T. Prevalence of pruritus in a single cohort of long-term kidney transplant recipients. Acta Derm Venereol. 2020;100(4):adv00066. doi:10.2340/00015555-3421
  • Hsu CW, Weng CH, Chan MJ, Lin-Tan DT, Yen TH, Huang WH. association between serum aluminum level and uremic pruritus in hemodialysis patients. Sci Rep. 2018;8(1):17251. doi:10.1038/s41598-018-35217-6
  • Hu T, Wang B, Liao X, Wang S. Clinical features and risk factors of pruritus in patients with chronic renal failure. Exp Ther Med. 2019;18:964–971. doi:10.3892/etm.2019.7588
  • O’Neill WC. The fallacy of the calcium-phosphorus product. Kidney Int. 2007;72:792–796. doi:10.1038/sj.ki.5002412
  • Momose A, Kudo S, Sato M, et al. Calcium ions are abnormally distributed in the skin of haemodialysis patients with uraemic pruritus. Nephrol Dial Transplant. 2004;19:2061–2066. doi:10.1093/ndt/gfh287
  • Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995;25(3):413–419. doi:10.1016/0272-6386(95)90102-7
  • Wu Q, Zhang H, Ding JR, et al. UPLC-QTOF MS-based serum metabolomic profiling analysis reveals the molecular perturbations underlying uremic pruritus. Biomed Res Int. 2018;2018:4351674. doi:10.1155/2018/4351674
  • Chen ZJ, Cao G, Tang WX, et al. A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clin Exp Dermatol. 2009;34(6):679–683. doi:10.1111/j.1365-2230.2008.03075.x
  • Lim JH, Park Y, Yook JM, et al. Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients. Sci Rep. 2020;10(1):7780. doi:10.1038/s41598-020-64622-z
  • Oweis AO, Al-Qarqaz F, Bodoor K, et al. Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus. Cytokine. 2021;138:155369. doi:10.1016/j.cyto.2020.155369
  • Kimmel M, Alscher DM, Dunst R, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant. 2006;21(3):749–755. doi:10.1093/ndt/gfi204
  • Leong SO, Tan CC, Lye WC, Lee EJ, Chan HL. Dermal mast cell density and pruritus in end-stage renal failure. Ann Acad Med Singap. 1994;23(3):327–329.
  • Dimković N, Djukanović L, Radmilović A, Bojić P, Juloski T. Uremic pruritus and skin mast cells. Nephron. 1992;61(1):5–9. doi:10.1159/000186826
  • Dugas-Breit S, Schöpf P, Dugas M, Schiffl H, Ruëff F, Przybilla B. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges. 2005;3(5):343–347. doi:10.1111/j.1610-0387.2005.05706.x
  • Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis. 2000;35(5):827–831. doi:10.1016/s0272-6386(00)70251-4
  • Vessal G, Sagheb MM, Shilian S, Jafari P, Samani SM. Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study. Nephrol Dial Transplant. 2010;25(5):1541–1547. doi:10.1093/ndt/gfp628
  • Mahmudpour M, Roozbeh J, Raiss Jalali GA, Pakfetrat M, Ezzat Zadegan S, Sagheb MM. Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients. Iran J Kidney Dis. 2017;11(1):50–55.
  • Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19(7):1895–1901. doi:10.1093/ndt/gfh202
  • Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006;66(3):184–191. doi:10.5414/cnp66184
  • Reszke R, Szepietowski JC. End-stage renal disease chronic itch and its management. Dermatol Clin. 2018;36(3):277–292. doi:10.1016/j.det.2018.02.007
  • Zakrzewska-Pniewska B, Jedras M. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Neurophysiol Clin. 2001;31(3):181–193. doi:10.1016/s0987-7053(01)00257-x
  • Martin CE, Clotet-Freixas S, Farragher JF, Hundemer GL. Have we just scratched the surface? A narrative review of uremic pruritus in 2020. Can J Kidney Health Dis. 2020;7:2054358120954024. doi:10.1177/2054358120954024
  • Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE. Specific C-receptors for itch in human skin. J Neurosci. 1997;17(20):8003–8008. doi:10.1523/JNEUROSCI.17-20-08003.1997
  • Namer B, Carr R, Johanek LM, Schmelz M, Handwerker HO, Ringkamp M. Separate peripheral pathways for pruritus in man. J Neurophysiol. 2008;100(4):2062–2069. doi:10.1152/jn.90482.2008
  • Handwerker HO. Microneurography of pruritus. Neurosci Lett. 2010;470(3):193–196. doi:10.1016/j.neulet.2009.06.092
  • Fantini F, Baraldi A, Sevignani C, Spattini A, Pincelli C, Giannetti A. Cutaneous innervation in chronic renal failure patients. An immunohistochemical study. Acta Derm Venereol. 1992;72(2):102–105.
  • Johansson O, Hilliges M, Ståhle-Bäckdahl M. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett. 1989;99(3):281–286. doi:10.1016/0304-3940(89)90460-6
  • Razeghi E, Eskandari D, Ganji MR, Meysamie AP, Togha M, Khashayar P. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail. 2009;31(2):85–90. doi:10.1080/08860220802595476
  • Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19(12):3137–3139. doi:10.1093/ndt/gfh496
  • Shavit L, Grenader T, Lifschitz M, Slotki I. Use of pregabalin in the management of chronic uremic pruritus. J Pain Symptom Manage. 2013;45(4):776–781. doi:10.1016/j.jpainsymman.2012.03.001
  • Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochim Biophys Acta. 2014;1842(7):869–892. doi:10.1016/j.bbadis.2014.02.007
  • Cevikbas F, Lerner EA. Physiology and pathophysiology of itch. Physiol Rev. 2020;100(3):945–982. doi:10.1152/physrev.00017.2019
  • Kumagai H, Saruta T, Matsukawa S, et al. Prospects for a novel kappa-opioid receptor agonist, TRK-820, in uremic pruritus. In: Yosipovitch G, Greaves MW, Fleischer JA, McGlone F, editors. Itch, Basic Mechanisms and Therapy. New York, NY: Dekker; 2004:279–286.
  • Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin Nephrol. 2015;35(4):383–391. doi:10.1016/j.semnephrol.2015.06.009
  • Lugon JR. Uremic pruritus: a review. Hemodial Int. 2005;9(2):180–188. doi:10.1111/j.1492-7535.2005.01130.x
  • Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11–20. doi:10.1053/j.ajkd.2007.03.010
  • Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis. 2017;70(5):638–655. doi:10.1053/j.ajkd.2017.05.018
  • Kozono H, Yoshitani H, Nakano R. Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3762 hemodialysis patients with intractable pruritus. Int J Nephrol Renovasc Dis. 2018;11:9–24. doi:10.2147/IJNRD.S145720
  • Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F. KALM-1 Trial Investigators. A Phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382(3):222–232. doi:10.1056/NEJMoa1912770
  • Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant. 2010;25(4):1251–1257. doi:10.1093/ndt/gfp588
  • Wikström B, Gellert R, Ladefoged SD, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16(12):3742–3747. doi:10.1681/ASN.2005020152
  • Pereira MP, Ständer S. Assessment of severity and burden of pruritus. Allergol Int. 2017;66(1):3–7. doi:10.1016/j.alit.2016.08.009
  • Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92(5):502–507. doi:10.2340/00015555-1246
  • Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329–338. doi:10.1007/BF00451725
  • Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587–593. doi:10.1111/j.1365-2133.2009.09586.x
  • Majeski CJ, Johnson JA, Davison SN, Lauzon CJ. Itch severity scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol. 2007;156(4):667–673. doi:10.1111/j.1365-2133.2006.07736.x
  • Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron. 1992;62:257–261. doi:10.1159/000187055
  • Carmichael AJ, Dickinson F, McHugh MI, Martin AM, Farrow M. Magnesium free dialysis for uraemic pruritus. BMJ. 1988;297(6663):1584–1585. doi:10.1136/bmj.297.6663.1584
  • Pederson JA, Matter BJ, Czerwinski AW, Llach F. Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med. 1980;93(3):446–448. doi:10.7326/0003-4819-93-3-446
  • Silverberg DS, Iaina A, Reisin E, Rotzak R, Eliahou HE. Cholestyramine in uraemic pruritus. Br Med J. 1977;1(6063):752–753. doi:10.1136/bmj.1.6063.752
  • Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96(1):7–26. doi:10.1093/qjmed/hcg002
  • Szepietowski JC, Szepietowski T, Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. Acta Dermatovenerol Croat. 2005;13(2):97–103.
  • Balaskas E, Szepietowski JC, Bessis D, et al. Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol. 2011;6(4):748–752. doi:10.2215/CJN.05490610
  • Duque MI, Yosipovitch G, Fleischer AB, Willard J, Freedman BI. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol. 2005;52(3 Pt 1):519–521. doi:10.1016/j.jaad.2004.08.050
  • Weisshaar E, Dunker N, Röhl FW, Gollnick H. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol. 2004;13:298–304. doi:10.1111/j.0906-6705.2004.00184.x
  • Marquez D, Ramonda C, Lauxmann JE, et al. Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin. J Bras Nefrol. 2012;34(2):148–152. doi:10.1590/s0101-28002012000200007
  • Brennan FP, Josland E, Kelly JJ. Chronic pruritus: histamine is not always the answer. J Pain Symptom Manage. 2015;50(4):566–570. doi:10.1016/j.jpainsymman.2015.04.009
  • Schwartz IF, Iaina A. Uraemic pruritus. Nephrol Dial Transplant. 1999;14:834–839. doi:10.1093/ndt/14.4.834
  • Feily A, Dormanesh B, Ghorbani AR, et al. Efficacy of topical cromolyn sodium 4% on pruritus in uremic nephrogenic patients: a randomized double-blind study in 60 patients. Int J Clin Pharmacol Ther. 2012;50(7):510–513. doi:10.5414/cp201629
  • Omidian M, Khazanee A, Yaghoobi R, et al. Therapeutic effect of oral nicotinamide on refractory uremic pruritus: a randomized, double-blind study. Saudi J Kidney Dis Transpl. 2013;24(5):995–999. doi:10.4103/1319-2442.118070
  • Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med. 1977;297(3):136–138. doi:10.1056/NEJM197707212970304
  • Nofal E, Farag F, Nofal A, Eldesouky F, Alkot R, Abdelkhalik Z. Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature. J Dermatolog Treat. 2016;27(6):515–519. doi:10.3109/09546634.2016.1161161
  • Foroutan N, Etminan A, Nikvarz N, Shojai Shahrokh Abadi M. Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial. Hemodial Int. 2017;21(1):63–71. doi:10.1111/hdi.12455
  • Yue J, Jiao S, Xiao Y, Ren W, Zhao T, Meng J. Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol. 2015;47(1):161–167. doi:10.1007/s11255-014-0795-x
  • Eusebio-Alpapara KMV, Castillo RL, Dofitas BL. Gabapentin for uremic pruritus: a systematic review of randomized controlled trials. Int J Dermatol. 2020;59(4):412–422. doi:10.1111/ijd.14708
  • Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11(3):514–519. doi:10.1681/ASN.V113514
  • Legroux-Crespel E, Clèdes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology. 2004;208(4):326–330. doi:10.1159/000077841
  • Weiner DE, Walpen S, Schaufler T, et al. Itch reduction with difelikefalin correlates with improved sleep quality in hemodialysis patients with pruritus. Oral Present ASN Kidney Week. 2021;2021:FR–OR 26.
  • Fishbane S, Wen W, Munera C, et al. Efficacy of difelikefalin in patients with moderate-to-severe chronic kidney disease–associated pruritus: pooled subgroup analysis of KALM-1 and KALM-2. Am J Kidney Dis. 2021;77:593–594. doi:10.1053/j.ajkd.2021.02.092